Inhaled anesthetics represent significant drug costs for anesthesia care, and previously, there have been limited or unreliable ways to measure the efficient use of anesthetics. In addition, the negative environmental impact of volatile anesthetics is a growing concern, so there is an increased focus on responsibly delivering an anesthetic. Low-flow anesthesia has gained popularity due to recent advances in anesthesia machines and CO 2 absorbents, which allow anesthesiologists to use low-flow anesthesia and develop an environmentally and financially conscious practice more easily than before. This quality improvement initiative was designed focusing on the efficient use of sevoflurane to limit the costs incurred from sevoflurane overuse and translate this improvement to carbon footprint equivalents of miles driven by an average car, gallons of gasoline, and pounds of coal burned.